Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation for the second quarter and half year ended 30th September, 2025
Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Investor Presentation On Financial Results BSE India Investor Presentation on Financial Results for the quarter ended 30th June 2025
Investor Presentation SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for the Quarter and year ended 31st March, 2025
Investor Presentation SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results
Investor Presentation SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for Financial Results for the period ended 30th September 2024
Investor Presentation SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation of the Company for the quarter ended 30th June, 2024
Investor Presentation SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results